ES8103048A1 - Un procedimiento para preparar derivados del acido 4-amino-3-quimoleincarboxilico. - Google Patents
Un procedimiento para preparar derivados del acido 4-amino-3-quimoleincarboxilico.Info
- Publication number
- ES8103048A1 ES8103048A1 ES489887A ES489887A ES8103048A1 ES 8103048 A1 ES8103048 A1 ES 8103048A1 ES 489887 A ES489887 A ES 489887A ES 489887 A ES489887 A ES 489887A ES 8103048 A1 ES8103048 A1 ES 8103048A1
- Authority
- ES
- Spain
- Prior art keywords
- amino
- esters
- antisecretory
- quinolinecarboxylic acids
- ulcer compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- UEFKMJWKPVAVND-UHFFFAOYSA-N 4-aminoquinoline-3-carboxylic acid Chemical class C1=CC=C2C(N)=C(C(O)=O)C=NC2=C1 UEFKMJWKPVAVND-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000000767 anti-ulcer Effects 0.000 title 1
- 208000008469 Peptic Ulcer Diseases 0.000 abstract 1
- 230000001262 anti-secretory effect Effects 0.000 abstract 1
- -1 compound ethyl 8-methoxy-4-[(2-methylphenyl)amino]-3-quinolinecarboxylate Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2398179A | 1979-03-26 | 1979-03-26 | |
| US06/127,153 US4343804A (en) | 1979-03-26 | 1980-03-04 | 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES489887A0 ES489887A0 (es) | 1981-02-16 |
| ES8103048A1 true ES8103048A1 (es) | 1981-02-16 |
Family
ID=26697875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES489887A Expired ES8103048A1 (es) | 1979-03-26 | 1980-03-25 | Un procedimiento para preparar derivados del acido 4-amino-3-quimoleincarboxilico. |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US4343804A (OSRAM) |
| JP (1) | JPH02117663A (OSRAM) |
| AR (1) | AR230268A1 (OSRAM) |
| AT (1) | AT372373B (OSRAM) |
| AU (1) | AU528388B2 (OSRAM) |
| BR (1) | BR8001779A (OSRAM) |
| CA (1) | CA1147338A (OSRAM) |
| CH (1) | CH644105A5 (OSRAM) |
| DE (1) | DE3011490A1 (OSRAM) |
| DK (1) | DK156056C (OSRAM) |
| EG (1) | EG15009A (OSRAM) |
| ES (1) | ES8103048A1 (OSRAM) |
| FI (1) | FI77452C (OSRAM) |
| FR (1) | FR2452485B1 (OSRAM) |
| GB (1) | GB2047244B (OSRAM) |
| GR (1) | GR68006B (OSRAM) |
| HK (1) | HK67983A (OSRAM) |
| IE (1) | IE49577B1 (OSRAM) |
| IL (1) | IL59628A (OSRAM) |
| IN (1) | IN151446B (OSRAM) |
| IT (1) | IT1133079B (OSRAM) |
| MX (1) | MX6264E (OSRAM) |
| NL (1) | NL8001752A (OSRAM) |
| NO (1) | NO153927C (OSRAM) |
| NZ (1) | NZ193252A (OSRAM) |
| PH (1) | PH16416A (OSRAM) |
| PL (1) | PL125030B1 (OSRAM) |
| PT (1) | PT71008B (OSRAM) |
| SE (1) | SE435837B (OSRAM) |
| SG (1) | SG33683G (OSRAM) |
| YU (1) | YU41702B (OSRAM) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8610981D0 (en) * | 1986-05-06 | 1986-06-11 | Ici America Inc | Quinoline amides |
| GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
| GB8804447D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804444D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804445D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804446D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804443D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804448D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| US5432182A (en) * | 1989-02-23 | 1995-07-11 | Smithkline Beecham Intercredit B.V. | Compounds substituted quinoline derivatives |
| CA2011086A1 (en) * | 1989-03-17 | 1990-09-17 | Karl-Heinz Geiss | 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom |
| DE3917233A1 (de) * | 1989-05-26 | 1990-11-29 | Basf Ag | 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel |
| GB8918265D0 (en) * | 1989-08-10 | 1989-09-20 | Smithkline Beckman Intercredit | Compounds |
| US5362743A (en) * | 1993-03-09 | 1994-11-08 | Pfizer Inc. | Aminoquinoline derivatives |
| IS4164A (is) * | 1993-06-11 | 1994-12-12 | Ab Astra | Efnasambönd sem hindra flæði magasýru |
| US5556863A (en) * | 1993-06-11 | 1996-09-17 | Astra Aktiebolag | Compound for gastric acid secretion inhibition |
| EP0720601B1 (en) * | 1993-08-10 | 2000-10-25 | James Black Foundation Limited | Gastrin and cck receptor ligands |
| US5650415A (en) * | 1995-06-07 | 1997-07-22 | Sugen, Inc. | Quinoline compounds |
| KR0169813B1 (ko) * | 1995-07-12 | 1999-01-15 | 김종인 | 4-아미노-3-아실나프티리딘 유도체 |
| US5760041A (en) * | 1996-02-05 | 1998-06-02 | American Cyanamid Company | 4-aminoquinazoline EGFR Inhibitors |
| US6875769B2 (en) * | 1996-05-23 | 2005-04-05 | Pfizer Inc. | Substituted6,6-hetero-bicyclicderivatives |
| US5929080A (en) * | 1997-05-06 | 1999-07-27 | American Cyanamid Company | Method of treating polycystic kidney disease |
| US6251912B1 (en) | 1997-08-01 | 2001-06-26 | American Cyanamid Company | Substituted quinazoline derivatives |
| US6323209B1 (en) | 1997-11-06 | 2001-11-27 | American Cyanamid Company | Method of treating or inhibiting colonic polyps |
| HU230728B1 (hu) | 1998-09-29 | 2017-12-28 | Wyeth Holdings Llc | Szubsztituált 3-cianokinolinok mint protein tirozin kinázok inhibitorai |
| WO2001047891A1 (en) * | 1999-12-28 | 2001-07-05 | Eisai Co., Ltd. | Heterocyclic compounds having sulfonamide groups |
| US6521618B2 (en) | 2000-03-28 | 2003-02-18 | Wyeth | 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| US6576644B2 (en) * | 2000-09-06 | 2003-06-10 | Bristol-Myers Squibb Co. | Quinoline inhibitors of cGMP phosphodiesterase |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| ES2295816T3 (es) | 2003-01-14 | 2008-04-16 | Arena Pharmaceuticals, Inc. | Derivados arilo y heteroarilo 1,2,3-trisustituidos como moduladores del metabolismo, y profilaxis y tratamiento de transtornos relacionados con los mismos, tales como la diabetes y la hiperglucemia. |
| HRP20050399B1 (hr) | 2003-03-10 | 2013-09-30 | Takeda Gmbh | Novi postupci za dobivanje roflumilasta |
| US7132426B2 (en) * | 2003-07-14 | 2006-11-07 | Arena Pharmaceuticals, Inc. | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| US8663694B2 (en) * | 2005-03-16 | 2014-03-04 | Takeda Gmbh | Taste masked dosage form containing roflumilast |
| WO2011022216A1 (en) * | 2009-08-17 | 2011-02-24 | High Point Pharmaceuticals, Llc | Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress |
| SG10201500639TA (en) | 2010-01-27 | 2015-03-30 | Arena Pharm Inc | Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
| EP2619198A1 (en) | 2010-09-22 | 2013-07-31 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| PL3242666T3 (pl) | 2015-01-06 | 2025-02-17 | Arena Pharmaceuticals, Inc. | Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1 |
| JP6838744B2 (ja) | 2015-06-22 | 2021-03-03 | アリーナ ファーマシューティカルズ， インコーポレイテッド | Ｓ１Ｐ１レセプター関連障害における使用のための（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸（化合物１）の結晶性Ｌ−アルギニン塩 |
| ES2884073T3 (es) * | 2016-11-11 | 2021-12-10 | Bayer Animal Health Gmbh | Nuevos derivados antihelmínticos de quinolina-3-carboxamida |
| AU2018220521A1 (en) | 2017-02-16 | 2019-09-05 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
| EP3700527A4 (en) * | 2017-10-25 | 2021-03-10 | Children's Medical Center Corporation | PAPD5 INHIBITORS AND METHOD OF USING THEM |
| EP3790874B1 (en) | 2018-05-09 | 2023-03-15 | Bayer Animal Health GmbH | Anthelmintic quinoline derivatives |
| KR102859841B1 (ko) | 2018-06-06 | 2025-09-12 | 아레나 파마슈티칼스, 인크. | S1p1 수용체와 관련된 병태의 치료 방법 |
| CN119798159A (zh) | 2019-04-24 | 2025-04-11 | 儿童医学中心公司 | Papd5抑制剂及其使用方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3470186A (en) * | 1967-06-02 | 1969-09-30 | American Cyanamid Co | Substituted 4-anilino-3-quinolinecarboxylic acids and esters |
| JPS4838712A (OSRAM) * | 1971-09-18 | 1973-06-07 |
-
1980
- 1980-03-04 US US06/127,153 patent/US4343804A/en not_active Expired - Lifetime
- 1980-03-14 IL IL59628A patent/IL59628A/xx unknown
- 1980-03-22 GR GR61513A patent/GR68006B/el unknown
- 1980-03-24 AT AT0156480A patent/AT372373B/de not_active IP Right Cessation
- 1980-03-24 FI FI800910A patent/FI77452C/fi not_active IP Right Cessation
- 1980-03-24 FR FR8006516A patent/FR2452485B1/fr not_active Expired
- 1980-03-24 IE IE605/80A patent/IE49577B1/en unknown
- 1980-03-24 MX MX808722U patent/MX6264E/es unknown
- 1980-03-25 DK DK128380A patent/DK156056C/da not_active IP Right Cessation
- 1980-03-25 DE DE19803011490 patent/DE3011490A1/de active Granted
- 1980-03-25 ES ES489887A patent/ES8103048A1/es not_active Expired
- 1980-03-25 IN IN345/CAL/80A patent/IN151446B/en unknown
- 1980-03-25 PH PH23804A patent/PH16416A/en unknown
- 1980-03-25 EG EG80174A patent/EG15009A/xx active
- 1980-03-25 PL PL1980222993A patent/PL125030B1/pl unknown
- 1980-03-25 NL NL8001752A patent/NL8001752A/nl not_active Application Discontinuation
- 1980-03-25 CH CH234080A patent/CH644105A5/fr not_active IP Right Cessation
- 1980-03-25 SE SE8002292A patent/SE435837B/sv not_active IP Right Cessation
- 1980-03-25 BR BR8001779A patent/BR8001779A/pt unknown
- 1980-03-25 NZ NZ193252A patent/NZ193252A/en unknown
- 1980-03-25 GB GB8009991A patent/GB2047244B/en not_active Expired
- 1980-03-25 NO NO800858A patent/NO153927C/no unknown
- 1980-03-25 PT PT71008A patent/PT71008B/pt unknown
- 1980-03-26 IT IT67465/80A patent/IT1133079B/it active
- 1980-03-26 AU AU56848/80A patent/AU528388B2/en not_active Ceased
- 1980-03-26 AR AR280455A patent/AR230268A1/es active
- 1980-03-26 YU YU844/80A patent/YU41702B/xx unknown
- 1980-03-26 CA CA000348417A patent/CA1147338A/en not_active Expired
-
1983
- 1983-06-13 SG SG336/83A patent/SG33683G/en unknown
- 1983-12-15 HK HK679/83A patent/HK67983A/xx unknown
-
1989
- 1989-09-26 JP JP1250369A patent/JPH02117663A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8103048A1 (es) | Un procedimiento para preparar derivados del acido 4-amino-3-quimoleincarboxilico. | |
| MY101891A (en) | Novel carbostyril derivative and process for preparing same. | |
| JPS52136121A (en) | Compound useful as depressor for angiotensin transforming enzyme and its method of manufacturing | |
| IE40858L (en) | 2-heterocyclylalkylthiobenzimidazoles | |
| AU527516B2 (en) | (d1)-16-phenoxy-and 16-substituted phenoxy-9-keto prostatrienoic acid derivatives | |
| AU4344889A (en) | Process for the preparation of 7-substituted-hept-6-enoic and-heptanoic acids and derivatives | |
| MY131384A (en) | Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof | |
| PH14891A (en) | A method of treating hypertension by administering a derivative of para-aminobenzoic acid | |
| GB1509860A (en) | Process for the manufacture of carbodiimides | |
| UA19160A (uk) | Спосіб одержаhhя алкілаhіліhофумарату | |
| MY101645A (en) | Phosphoric esters and process for preparing the same. | |
| EP0104611A3 (en) | Thiatriazine derivatives | |
| DE3261759D1 (en) | Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor | |
| CA1273347C (OSRAM) | ||
| IE40634B1 (en) | Vinacmine 2-ketoglutarate and process for the production thereof | |
| AU542522B2 (en) | Alpha-substituted ureidobenzylpenicillanic acid and process for producing the same | |
| UA13316A (uk) | Спосіб боротьби з hебажаhим ростом рослиh | |
| JPS5699480A (en) | Preparation of pyridopyrimidine derivative | |
| JPS51138691A (en) | Process for preparing novel b is-penicillins | |
| JPS5651483A (en) | 1-azaxanthone 3-carboxylic acid derivative and its preparation | |
| JPS5283360A (en) | (e)-5-(beta-substituted vinyl)-2-thienylacetic acids | |
| JPS56166158A (en) | Novel benzyloxycarbonyl-leucyl-leucyl-valyl-4-amino-3- hydroxy-6-methyl-heptanoyl-alanine and its preparation | |
| BG37445A1 (en) | Alkyl esters of 5- chlor- 2- keto- bicyclo (2, 2, 1) heptane- 7- carbonic acid and method for its preparing | |
| JPS52116490A (en) | Novel 7alpha-methoxycephalosporanic acid derivatives and method of preparing the same | |
| ES8505937A1 (es) | Un metodo para la preparacion de una 2-metil-4-hidroxi-2h-1, 2-benzotiacin-1, 1-dioxido-3-(n-2-piridil)-carboxamida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |
Effective date: 19960401 |